Halozyme Therapeutics, Inc. HALO
2 targets with a reported result
Releases of the last 3 yearsThe numbers HALO said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| EBITDA (company-defined) Fiscal 2026 |
Given $1.12B to $1.21B release Jan 28, 2026
Kept $1.12B to $1.21B release Feb 17, 2026
Kept $1.12B to $1.21B release May 11, 2026
Raised $1.23B to $1.28B release Aug 6, 2026
Raised $1.24B to $1.29B release Nov 5, 2026
|
– | No standard number | |
The company's wordsRaises 2026 Financial Guidance Ranges: … - Increases Adjusted EBITDA to $1,125 - $1,205 million 3,4 release Jan 28, 2026 Reiterating 2026 Financial Guidance Ranges: … Adjusted EBITDA of $1.125 - $1.205 billion, YOY Growth of 71% - 83% 1 release Feb 17, 2026 Reiterating 2026 Financial Guidance Ranges: … Adjusted EBITDA of $1.125 - $1.205 billion, YOY Growth of 71% - 83% 1 release May 11, 2026 Raises 2026 Financial Guidance Ranges: … Adjusted EBITDA of $1.225 - $1.280 billion, YOY Growth of 86% - 95% 1 release Aug 6, 2026 Raising 2026 Financial Guidance Ranges: … Adjusted EBITDA of $1.240 - $1.290 billion, YOY Growth of 89% - 96% 1 release Nov 5, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2026 |
Given $7.75 to $8.25 release Jan 28, 2026
Kept $7.75 to $8.25 release Feb 17, 2026
Kept $7.75 to $8.25 release May 11, 2026
Raised $8.65 to $9.00 release Aug 6, 2026
Raised $8.75 to $9.05 release Nov 5, 2026
|
– | No standard number | |
The company's wordsRaises 2026 Financial Guidance Ranges: … - Increases non-GAAP Diluted EPS to $7.75 - $8.25 3,4 release Jan 28, 2026 Reiterating 2026 Financial Guidance Ranges: … Non-GAAP Diluted EPS of $7.75 - $8.25, YOY Growth of 87% - 99% 1 release Feb 17, 2026 Reiterating 2026 Financial Guidance Ranges: … Non-GAAP Diluted EPS of $7.75 - $8.25, YOY Growth of 87% - 99% 1 release May 11, 2026 Raises 2026 Financial Guidance Ranges: … Non-GAAP Diluted EPS of $8.65 - $9.00, YOY Growth of 108% - 117% 1 release Aug 6, 2026 Raising 2026 Financial Guidance Ranges: … Non-GAAP Diluted EPS of $8.75 - $9.05, YOY Growth of 111% - 118% 1 release Nov 5, 2026 | ||||
| Revenue Fiscal 2026 |
Given $1.39B to $1.40B release Jan 28, 2026
Raised $1.71B to $1.81B release Feb 17, 2026
Kept $1.71B to $1.81B release May 11, 2026
Raised $1.83B to $1.91B release Aug 6, 2026
Raised $1.86B to $1.93B release Nov 5, 2026
|
– | Not reported yet | |
The company's wordsRaises 2026 and Multi-Year Financial Guidance … - Total Revenue of $1,385 - $1,400 million, YoY Growth of 36% to 38% 1 release Jan 28, 2026 Reiterating 2026 Financial Guidance Ranges: … Total Revenue of $1.710 - $1.810 billion, YOY Growth of 22% - 30% release Feb 17, 2026 Reiterating 2026 Financial Guidance Ranges: … Total Revenue of $1.710 - $1.810 billion, YOY Growth of 22% - 30% release May 11, 2026 Raises 2026 Financial Guidance Ranges: … Total Revenue of $1.835 - $1.910 billion, YOY Growth of 31% - 37% release Aug 6, 2026 Raising 2026 Financial Guidance Ranges: … Total Revenue of $1.860 - $1.925 billion, YOY Growth of 33% - 38% release Nov 5, 2026 | ||||
| EBITDA (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $755.00M to $805.00M release Jan 8, 2025
Kept $755.00M to $805.00M release Feb 18, 2025
Raised $790.00M to $840.00M release May 6, 2025
Raised $865.00M to $915.00M release Aug 5, 2025
Raised $885.00M to $935.00M release Nov 3, 2025
|
– | No standard number | |
The company's wordsRaises 2025 Financial Guidance Ranges for Total Revenue to $1,150 - $1,225 million, Representing YoY Growth of 16% - 23%, Adjusted EBITDA of $755 - $805 million, Representing YoY Growth of 24% - 32%, and non-GAAP Diluted EPS of $4.95 - $5.35, Representing YoY Growth of 21% - 30% 1,2 release Jan 8, 2025 Reiterating 2025 Financial Guidance Ranges for Total Revenue of $1,150 - 1,225 million, Representing YOY Growth of 13% - 21%, Adjusted EBITDA of $755 - $805 million, Representing YOY Growth of 19% - 27% and non-GAAP Diluted EPS of $4.95 - $5.35, Representing YOY Growth of 17% - 26% 1 release Feb 18, 2025 Raising 2025 Financial Guidance Ranges for Total Revenue to $1,200 - $1,280 million, Representing YOY Growth of 18% - 26%, Adjusted EBITDA to $790 - $840 million, Representing YOY Growth of 25% - 33% and non-GAAP Diluted EPS to $5.30 - $5.70, Representing YOY Growth of 25% - 35% 1 release May 6, 2025 Raising 2025 Financial Guidance Ranges for Total Revenue to $1,275 - $1,355 million, Representing YOY Growth of 26% - 33%, Adjusted EBITDA to $865 - $915 million, Representing YOY Growth of 37% - 45% and Non-GAAP Diluted EPS to $6.00 - $6.40, Representing YOY Growth of 42% - 51% 1 release Aug 5, 2025 Raising 2025 Financial Guidance Ranges for Total Revenue to $1,300 - $1,375 million, Representing YOY Growth of 28% - 35%, Adjusted EBITDA to $885 - $935 million, Representing YOY Growth of 40% - 48% and Non-GAAP Diluted EPS to $6.10 - $6.50, Representing YOY Growth of 44% - 54% 1 release Nov 3, 2025 | ||||
| Diluted EPS (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $4.95 to $5.35 release Jan 8, 2025
Kept $4.95 to $5.35 release Feb 18, 2025
Raised $5.30 to $5.70 release May 6, 2025
Raised $6.00 to $6.40 release Aug 5, 2025
Raised $6.10 to $6.50 release Nov 3, 2025
|
– | No standard number | |
The company's wordsRaises 2025 Financial Guidance Ranges for Total Revenue to $1,150 - $1,225 million, Representing YoY Growth of 16% - 23%, Adjusted EBITDA of $755 - $805 million, Representing YoY Growth of 24% - 32%, and non-GAAP Diluted EPS of $4.95 - $5.35, Representing YoY Growth of 21% - 30% 1,2 release Jan 8, 2025 Reiterating 2025 Financial Guidance Ranges for Total Revenue of $1,150 - 1,225 million, Representing YOY Growth of 13% - 21%, Adjusted EBITDA of $755 - $805 million, Representing YOY Growth of 19% - 27% and non-GAAP Diluted EPS of $4.95 - $5.35, Representing YOY Growth of 17% - 26% 1 release Feb 18, 2025 Raising 2025 Financial Guidance Ranges for Total Revenue to $1,200 - $1,280 million, Representing YOY Growth of 18% - 26%, Adjusted EBITDA to $790 - $840 million, Representing YOY Growth of 25% - 33% and non-GAAP Diluted EPS to $5.30 - $5.70, Representing YOY Growth of 25% - 35% 1 release May 6, 2025 Raising 2025 Financial Guidance Ranges for Total Revenue to $1,275 - $1,355 million, Representing YOY Growth of 26% - 33%, Adjusted EBITDA to $865 - $915 million, Representing YOY Growth of 37% - 45% and Non-GAAP Diluted EPS to $6.00 - $6.40, Representing YOY Growth of 42% - 51% 1 release Aug 5, 2025 Raising 2025 Financial Guidance Ranges for Total Revenue to $1,300 - $1,375 million, Representing YOY Growth of 28% - 35%, Adjusted EBITDA to $885 - $935 million, Representing YOY Growth of 40% - 48% and Non-GAAP Diluted EPS to $6.10 - $6.50, Representing YOY Growth of 44% - 54% 1 release Nov 3, 2025 | ||||
| Revenue Fiscal 2025 (ended Dec 31, 2025) |
Given $1.15B to $1.23B release Jan 8, 2025
Kept $1.15B to $1.23B release Feb 18, 2025
Raised $1.20B to $1.28B release May 6, 2025
Raised $1.27B to $1.35B release Aug 5, 2025
Raised $1.30B to $1.38B release Nov 3, 2025
|
$1.40B 10-K filed 2026-02-17 |
Above the range | |
The company's wordsPrevious New Guidance Expected YoY Guidance Range Range Growth1 … Total Revenue million $1,150 to $1,225 million release Jan 8, 2025 For the full year 2025, the Company expects: … Total revenue of $1,150 million to $1,225 million, representing growth of 13% to 21% over 2024 total revenue, primarily driven by increases in royalty revenue and product sales from XYOSTED ® . release Feb 18, 2025 For the full year 2025, the Company expects: … Total revenue of $1,200 million to $1,280 million, representing growth of 18% to 26% over 2024 total revenue, primarily driven by increases in royalty revenue. release May 6, 2025 For the full year 2025, the Company expects: … Total revenue of $1,275 million to $1,355 million, representing growth of 26% to 33% over 2024 total revenue, primarily driven by increases in royalty revenue. release Aug 5, 2025 For the full year 2025, the Company expects: … Total revenue of $1,300 million to $1,375 million, representing growth of 28% to 35% over 2024 total revenue, primarily driven by increases in royalty revenue. release Nov 3, 2025 | ||||
| EBITDA (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $535.00M to $585.00M release Feb 20, 2024
Kept $535.00M to $585.00M release May 7, 2024
Raised $555.00M to $615.00M release Aug 6, 2024
Raised $595.00M to $625.00M release Oct 31, 2024
|
– | No standard number | |
The company's wordsReiterating 2024 Financial Guidance: Total Revenue of $915-985 Million, Representing YOY Growth of 10-19%, Adjusted EBITDA of $535-585 Million, Representing YOY Growth of 26- 37% and Non-GAAP Diluted EPS of $3.55-3.90, Representing YOY Growth of 28-41% release Feb 20, 2024 Reiterating 2024 Financial Guidance: Total Revenue of $915 - $985 million, Representing YOY Growth of 10% - 19%, Adjusted EBITDA of $535 - $585 million, Representing YOY Growth of 26% - 37% and Non-GAAP Diluted EPS of $3.55 - $3.90, Representing YOY Growth of 28% - 41% release May 7, 2024 Maintain Recently Increased 2024 Financial Guidance: Total Revenue of $935 - $1,015 million, Representing YOY Growth of 13% - 22%, Adjusted EBITDA of $555 - $615 million, Representing YOY Growth of 30% - 44% and Non-GAAP Diluted EPS of $3.65 - $4.05, Representing YOY Growth of 32% - 46% release Aug 6, 2024 Raised 2024 Financial Guidance Ranges for Total Revenue of $970-$1,020 million, Representing YOY Growth of 17%-23%, Adjusted EBITDA of $595-$625 million, Representing YOY Growth of 40%-47%, and Non-GAAP Diluted EPS of $4.00-$4.20, Representing YOY Growth of 44%-52% release Oct 31, 2024 | ||||
| Diluted EPS (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given $3.55 to $3.90 release Feb 20, 2024
Kept $3.55 to $3.90 release May 7, 2024
Raised $3.65 to $4.05 release Aug 6, 2024
Raised $4.00 to $4.20 release Oct 31, 2024
|
– | No standard number | |
The company's wordsReiterating 2024 Financial Guidance: Total Revenue of $915-985 Million, Representing YOY Growth of 10-19%, Adjusted EBITDA of $535-585 Million, Representing YOY Growth of 26- 37% and Non-GAAP Diluted EPS of $3.55-3.90, Representing YOY Growth of 28-41% release Feb 20, 2024 Reiterating 2024 Financial Guidance: Total Revenue of $915 - $985 million, Representing YOY Growth of 10% - 19%, Adjusted EBITDA of $535 - $585 million, Representing YOY Growth of 26% - 37% and Non-GAAP Diluted EPS of $3.55 - $3.90, Representing YOY Growth of 28% - 41% release May 7, 2024 Maintain Recently Increased 2024 Financial Guidance: Total Revenue of $935 - $1,015 million, Representing YOY Growth of 13% - 22%, Adjusted EBITDA of $555 - $615 million, Representing YOY Growth of 30% - 44% and Non-GAAP Diluted EPS of $3.65 - $4.05, Representing YOY Growth of 32% - 46% release Aug 6, 2024 Raised 2024 Financial Guidance Ranges for Total Revenue of $970-$1,020 million, Representing YOY Growth of 17%-23%, Adjusted EBITDA of $595-$625 million, Representing YOY Growth of 40%-47%, and Non-GAAP Diluted EPS of $4.00-$4.20, Representing YOY Growth of 44%-52% release Oct 31, 2024 | ||||
| Revenue Fiscal 2024 (ended Dec 31, 2024) |
Given $915.00M to $985.00M release Feb 20, 2024
Kept $915.00M to $985.00M release May 7, 2024
Raised $935.00M to $1.01B release Aug 6, 2024
Raised $970.00M to $1.02B release Oct 31, 2024
|
$1.02B 10-K filed 2025-02-18 |
Within the range | |
The company's wordsGuidance Range … Total Revenue $915 to $985 million release Feb 20, 2024 Guidance Range … Total Revenue $915 to $985 million release May 7, 2024 Guidance Range … Total Revenue $935 to $1,015 million release Aug 6, 2024 Previous Guidance Range New Guidance Range … Total Revenue $970 to $1,020 million release Oct 31, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (14 releases since 2024-02-20), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HALO/export.csv") into a cell.